Pill Identifier Excedrin Extra Strength Geltabs - NDC 0067-2021
Acetaminophen, Asprin, Caffeine
Product Code 0067-2021
Excedrin Extra Strength Geltabs by Glaxosmithkline Consumer Healthcare Holdings (us) Llc is a green and white rou tablet coated about 18 mm in size, imprinted with e. The product is a human otc drug with active ingredient(s) acetaminophen, asprin, caffeine.
Excedrin Extra Strength Geltabs
Active Ingredient(s): Acetaminophen, Asprin, Caffeine
Inactive Ingredient(s):
- BENZOIC ACID
- D&C YELLOW NO. 10
- EDETATE DISODIUM
- FD&C BLUE NO. 1
- FD&C RED NO. 40
- GELATIN, UNSPECIFIED
- GLYCERIN
- HYPROMELLOSE, UNSPECIFIED
- FERROSOFERRIC OXIDE
- ISOPROPYL ALCOHOL
- LACTOSE MONOHYDRATE
- LIGHT MINERAL OIL
- LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE, UNSPECIFIED
- MALTITOL
- MEDIUM-CHAIN TRIGLYCERIDES
- MICROCRYSTALLINE CELLULOSE
- PEPSIN
- POLYSORBATE 20
- POVIDONE, UNSPECIFIED
- PROPYL GALLATE
- PROPYLENE GLYCOL
- DIMETHICONE
- SILICON DIOXIDE
- SORBITAN MONOLAURATE
- STEARIC ACID
- TITANIUM DIOXIDE
Glaxosmithkline Consumer Healthcare Holdings (us) Llc
Product Type: Human Otc Drug
Dosage Form: Tablet, Coated
- Green (C48329)
- White (C48325)
Product Packages
NDC Package Code | Package Description |
---|---|
0067-2021-20 | 1 BOTTLE in 1 CARTON > 20 TABLET, COATED in 1 BOTTLE |
0067-2021-24 | 1 BOTTLE in 1 CARTON > 24 TABLET, COATED in 1 BOTTLE |
0067-2021-80 | 1 BOTTLE in 1 CARTON > 80 TABLET, COATED in 1 BOTTLE |
* Please review the disclaimer below.
Pill Identification data last updated on: December, 2018
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product. If this is an emergency, call 911 or the national Poison Help hotline at 1-800-222-1222. Most images are not part of the product labels and have not been verified by the labeler company. ALWAYS consult your physician or pharmacist with any medication-related questions.